Prot# TAK-700_201: A Phase 1/2, Open-Label, Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of TAK-700 in Metastatic, Androgen-Independent Prostate Cancer Subjects

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/31/08 → 1/31/11

Funding

  • Takeda Development Center Americas, Inc. (TAK-700_201)
View all
View less